Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2010-08-26 Major Shareholding Noti…
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2010
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Before the transaction' vs. 'After the transaction') for a specific holder (Sofinnova Capital IV) in Orexo AB. It specifies the number of shares and voting rights before and after a 'Sell' transaction, and notes the resulting percentage of holdings. This structure perfectly matches the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The filing type code for this is MRQ.
2010-08-26 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is titled 'delårsrapport januari-juni 2010' (Interim Report January-June 2010) for Orexo AB. It contains comprehensive financial statements, including income statements, revenue breakdowns, and management commentary on business performance for the six-month period. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2010
2010-08-20 Swedish
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report, January-June 2010' for Orexo AB. It contains comprehensive financial statements, including a consolidated statement of operations, revenue breakdowns, and detailed management commentary on business performance for the specified interim period. It is not a mere announcement or certification, but the full interim financial report itself. H1 2010
2010-08-20 English
Board/Management Information 2010
Board/Management Information Classification · 1% confidence The document is a press release dated August 20, 2010, detailing strategic changes, initiation of new development projects (OX219, OX51, OX27), and an upcoming CEO change. It also announces a conference call for analysts and investors to discuss the updated strategy. This content—announcing strategic direction, pipeline updates, and management changes—is characteristic of a general corporate announcement or an earnings-related communication, but it is not a formal regulatory filing like a 10-K, a comprehensive Interim Report (IR), or a formal Earnings Release (ER) which typically focuses strictly on period financials. Since it announces strategic shifts and management changes, it aligns closely with general corporate news. However, the text also mentions that the information is what Orexo AB (publ) must disclose according to financial instrument laws, and it is a general announcement. Given the options, this type of broad strategic update, management change announcement, and pipeline progress report, issued as a press release, often falls under general regulatory disclosure or management updates. Since it explicitly discusses management changes (CEO succession planning) and strategic direction, 'Board/Management Information' (MANG) is a strong candidate. It also contains elements of an 'Earnings Release' (ER) by discussing strategy, but it lacks the typical structured financial tables of an ER. Because the core news involves management transition and strategic pivot, MANG is the most specific fit among the non-financial report categories. If MANG were not available, RNS would be the fallback. Given the strong focus on the CEO change and the board's recommendation for the outgoing CEO, MANG is selected.
2010-08-20 Swedish
Board/Management Information 2010
Board/Management Information Classification · 1% confidence The document is a press release dated August 20, 2010, announcing a strategic shift, the initiation of new development programs, and a change in CEO leadership. It details management changes (CEO search, recommendation for a non-executive director role for the outgoing CEO) and outlines future business strategy and R&D pipeline updates. This content strongly aligns with announcements regarding senior management changes and strategic direction, which falls under Board/Management Information (MANG). While it discusses financial strategy, it is not a formal financial report (like 10-K or IR) or a pure earnings release (ER). It is primarily focused on leadership and corporate structure changes.
2010-08-20 English
Board/Management Information 2010
Board/Management Information Classification · 1% confidence The document is a press release dated August 10, 2010, announcing a change in senior management: Robin Wright is appointed as the new Chief Financial Officer (CFO) and Head of Strategy, replacing Claes Wenthzel. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and is a direct announcement, not a comprehensive report or a general regulatory filing.
2010-08-10 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.